Nanjing Well Pharmaceutical Co Ltd Total Liabilities
Nanjing Well Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Nanjing Well Pharmaceutical Co Ltd (603351) has total liabilities worth CN¥787.30 Million CNY (≈ $115.21 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Nanjing Well Pharmaceutical Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Nanjing Well Pharmaceutical Co Ltd (2014–2025)
Total liabilities of Nanjing Well Pharmaceutical Co Ltd from 2014 to 2025. This chart illustrates how Nanjing Well Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Nanjing Well Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Nanjing Well Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Canadian Tire Corporation Limited
TO:CTC
|
Canada | CA$14.73 Billion |
|
Chularat Hospital Public Company Limited
BK:CHG
|
Thailand | ฿1.97 Billion |
|
China Hi-Tech Group Co Ltd
SHG:600730
|
China | CN¥228.71 Million |
|
LSI Industries Inc
NASDAQ:LYTS
|
USA | $148.21 Million |
|
Hainan Haiqi Transportation Group Co Ltd
SHG:603069
|
China | CN¥1.80 Billion |
|
Delixi Xinjiang Transp Co Ltd
SHG:603032
|
China | CN¥384.50 Million |
|
Ur Energy Inc
NYSE MKT:URG
|
USA | $80.27 Million |
|
Ability Opto-Electronics Technology Co Ltd
TWO:3362
|
Taiwan | NT$6.98 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Nanjing Well Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603351 current and non-current assets.
Liquidity & Leverage Metrics
Nanjing Well Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Nanjing Well Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanjing Well Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanjing Well Pharmaceutical Co Ltd (2014–2025)
The table below shows the annual total liabilities of Nanjing Well Pharmaceutical Co Ltd from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥791.01 Million ≈ $115.75 Million |
+17.58% |
| 2024-12-31 | CN¥672.72 Million ≈ $98.44 Million |
-1.97% |
| 2023-12-31 | CN¥686.22 Million ≈ $100.42 Million |
+4.65% |
| 2022-12-31 | CN¥655.76 Million ≈ $95.96 Million |
+43.80% |
| 2021-12-31 | CN¥456.01 Million ≈ $66.73 Million |
+35.41% |
| 2020-12-31 | CN¥336.75 Million ≈ $49.28 Million |
+55.15% |
| 2019-12-31 | CN¥217.06 Million ≈ $31.76 Million |
+12.12% |
| 2018-12-31 | CN¥193.59 Million ≈ $28.33 Million |
+0.45% |
| 2017-12-31 | CN¥192.73 Million ≈ $28.20 Million |
+23.35% |
| 2016-12-31 | CN¥156.25 Million ≈ $22.86 Million |
-19.05% |
| 2015-12-31 | CN¥193.01 Million ≈ $28.24 Million |
+7.86% |
| 2014-12-31 | CN¥178.94 Million ≈ $26.19 Million |
-- |
About Nanjing Well Pharmaceutical Co Ltd
Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China and internationally. The company offers excipients for injection, oral, and topical applications; and active pharmaceutical ingredients (API), such as polidocanol and polyethylene glycol 3… Read more